Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy

被引:20
|
作者
Weinberg, A
Pahwa, S
Oyomopito, R
Carey, VJ
Zimmer, B
Mofenson, L
Kovacs, A
Burchett, SK
机构
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA
[2] N Shore Univ Hosp, Manhasset, NY USA
[3] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[5] Childrens Hosp, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] NICHHD, NIH, Rockville, MD USA
[8] Los Angeles Cty Med Ctr, Los Angeles, CA USA
[9] Univ So Calif, Med Ctr, Los Angeles, CA USA
关键词
D O I
10.1086/420931
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To identify virological and immunological correlates of microbial-specific immune reconstitution in children with advanced human immunodeficiency virus (HIV) infection, Candida- and tetanus-specific lymphocyte proliferation was measured in 165 children initiating a new highly active antiretroviral therapy ( HAART) regimen. During the study, the proportions of children with immunity to Candida and tetanus increased from 53% to 66% and 19% to 22%, respectively. Tetanus immunity was associated with an HIV load less than or equal to400 RNA copies/mL and with Candida immunity. At the end of the study, 23% of the patients with baseline negative lymphocyte proliferation had tetanus immunity, and 65% had Candida immunity. Reconstitution of tetanus immunity correlated with lower end-of-study HIV loads and activated CD8(+) cell percentages and higher baseline and in-study CD4(+) cell percentages, but not with a gain of CD4(+) cells. Reconstitution of Candida immunity showed similar trends. In conclusion, children with advanced HIV infection receiving HAART reconstituted Candida immunity more readily than they did tetanus immunity, suggesting a role for antigen reexposure. Additional factors for immune reconstitution were low HIV load, high CD4(+) cell percentages, and low levels of activated CD8(+) cells.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [31] Immune reconstitution in human immunodeficiency virus-positive patients on highly active antiretroviral therapy at an urban public sector district hospital
    Jimoh, O. S.
    Naidoo, M.
    SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES, 2014, 29 (03) : 105 - 109
  • [32] Xanthomas and hyperlipidemia in a human immunodeficiency virus-infected child receiving highly active antiretroviral therapy
    Babl, FE
    Regan, AM
    Pelton, SI
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (03) : 259 - 260
  • [33] Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1
    Shafer, RW
    Vuitton, DA
    BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (02) : 73 - 86
  • [34] PERICARDIAL EFFUSION ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN THE ERA OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
    Strimel, William
    Stewart, David A., II
    Gantt, D. Scott
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [35] Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection
    Heath, KV
    Montaner, JSG
    Bondy, G
    Singer, J
    O'Shaughnessy, MV
    Hogg, RS
    CURRENT DRUG TARGETS, 2003, 4 (01) : 13 - 22
  • [36] Impact of highly active antiretroviral therapy on outcome of cholecystectomy in patients with human immunodeficiency virus infection
    Foschi, D.
    Cellerino, P.
    Corsi, F.
    Casali, A.
    Rizzi, A.
    Righi, I.
    Trabucchi, E.
    BRITISH JOURNAL OF SURGERY, 2006, 93 (11) : 1383 - 1389
  • [37] Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection
    Van Dyke, RB
    Lee, S
    Johnson, GM
    Wiznia, A
    Mohan, K
    Stanley, K
    Morse, EV
    Krogstad, PA
    Nachman, S
    PEDIATRICS, 2002, 109 (04) : e61
  • [38] Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?
    Breen, RAM
    Smith, CJ
    Cropley, I
    Johnson, MA
    Lipman, MCI
    AIDS, 2005, 19 (11) : 1201 - 1206
  • [39] Liver function in children with human immunodeficiency virus infection before and after 6 months of highly active antiretroviral therapy
    Sapulete, Eva Jacomina Jemima
    Putra, I. Gusti Ngurah Sanjaya
    Wati, Ketut Dewi Kumara
    Santoso, Hendra
    Witarini, Komang Ayu
    Karyana, I. Putu Gede
    Nesa, Ni Nyoman Metriani
    PAEDIATRICA INDONESIANA, 2018, 58 (04) : 159 - 164
  • [40] Pneumocystis Pneumonia in South African Children With and Without Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy
    Morrow, Brenda M.
    Hsaio, Nei-Yuan
    Zampoli, Marco
    Whitelaw, Andrew
    Zar, Heather J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (06) : 535 - 539